Ex-100 Reporting Season Playbook

About the author:

Josephine (Jo) Little
Author name:
By Josephine (Jo) Little
Job title:
Senior Analyst
Date posted:
28 July 2020, 1:00 PM
Sectors Covered:
Consumer Discretionary (Retail)

In our Ex-100 playbook, we preview our expectations for the 103 stocks in our ex-100 coverage that will report their results in August (Morgans clients only).

The quality of performance this period will likely be distorted by COVID-19 impacts and new accounting standards (ie. AASB16). We identify 20 stocks that we believe will likely have positive share price reactions to their results, six that will have negative reactions, and the remainder neutral.

Over 65% of the stocks in this report have provided a comprehensive trading update and/or FY20 guidance in May/June, perhaps dampening short-term earnings risk this reporting season.

Liquidity positions will be closely scrutinised and likely a focal point for management commentary.


Senior Analyst Jo Little identifies the stocks to watch ahead of the upcoming reporting season:

Ex-100 Playbook

Morgans clients can login to view full analysis and our expectations for 103 Ex-100 stocks ahead of reporting season. 

Reporting calendar

Individual company reporting dates, our stock recommendations and our analyst comments. View now.

More reporting season analysis

Find out more

Morgans clients can access further analysis by browsing the latest research on our client website. If you would like access or more information, please contact your adviser or nearest Morgans office.

Need access?

You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team

Create trial account 

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link